The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility
Key facts
- Who runs it
- Federal State Budgetary Scientific Institution
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Jul 2025
- Planned end
- 31 Dec 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- specialized food based on ice cream, order 1
- specialized food based on ice cream, order 2
- specialized food based on ice cream, order 3
- Record updated
- 14 August 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (22)Hide the full registry criteria
Who can take part
- willingness to participate based on signed written informed consent
- controlled glycemia. If stable glycemia is achieved on treatment, the following requirements should be met:
- no qualitative changes in treatment within 6 months before enrollment (i.e., the introduction of a new antidiabetic therapy)
- doses of anti-diabetic medications should be stable for 6 month in patients who receive metformin, gliptins, sulfonylureas, sodium/glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 agonists (GLP-1) or insulin
- no new medications during participation in the study
Who cannot take part
- Past major abdominal or chest surgery, including bariatric procedures and fundoplication (except appendectomy or cholecystectomy performed more than a year before enrollment)
- Clinically relevant acute cardiovascular event within 6 months prior to screening
- Chronic heart failure (I-IV class by NYHA)
- Major esophageal motility disorders according to Chicago IV classification
- Uncontrolled arterial hypertension despite optimal anti-hypertensive therapy
- Diabetes mellitus type 1
- Hypersensitivity to the studied product or any of its components, including lactose intolerance
- Any medical conditions that may significantly affect life expectancy, including known cancers
- Any clinically significant immunological, endocrine, hematological, gastrointestinal, neurological, tumor or psychiatric diseases
- The level of glycated hemoglobin [HbA1c] >9.0%
- The intake of any pharmaceutical agents with known influence on esophageal motility (including, but not limited to: beta-blockers, calcium channel blockers, m-cholinoblockers, myorelaxants, antidepressants, tranquilizers, prokinetic agents)
- Pregnancy and breastfeeding
- Liver cirrhosis based on liver histology, or liver stiffness measurement (LSM > or = 14 kPa by Fibroscan), or APRI > or= 1; or BARD score > or = 2
- Diarrhea of any type (watery stool more than 3 times a day)
- Achalasia and esophago-gastric junction outflow obstruction
- Mental instability or incapacity, which may impact the ability to give informed consent, take part in the study, or affect the ability to comply with the requirements of the study protocol
- Inability to tolerate high-resolution esophageal manometry without sedation, at least in part
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Ineffective esophageal motility or gerd
This trial is currently available in Russia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess the influence of specialized products based on ice cream on esophageal motility
The 3 groups in the trial
- Arm 1Treatment being tested
Subjects of this arm will receive the following sequence of products: 1 - ice cream with brazzein, maltitol and oligofructose, 2 - ice cream with brazzein, erythritol, maltitol and inulin; 3 - standard ice cream
Treatment: specialized food based on ice cream, order 1
- Arm 2Treatment being tested
Subjects of this arm will receive the following sequence of products: 1 - ice cream with brazzein, erythritol, maltitol and inulin; 2 - ice cream with brazzein, maltitol and oligofructose, 3 - standard ice cream
Treatment: specialized food based on ice cream, order 2
- Arm 3Treatment being tested
Subjects of this arm will receive the following sequence of products: 1 - standard ice cream; 2 - ice cream with brazzein, maltitol and oligofructose, 3 - ice cream with brazzein, erythritol, maltitol and inulin
Treatment: specialized food based on ice cream, order 3
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Analysis of Effects of Specialized Food Products Based on Ice-Cream on Esophageal Motility
- Criteria questions
- Built from NCT07121803, who can take part
- Record updated
- 14 August 2025